ARCHIVES

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

This article is from The Cancer Letter archive.

Vol. 37 No. 04 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Orders More Changes In ESA Label,

August 8, 2008

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized

March 13, 1981

Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture

April 7, 1978

Screening Frequency for Cervical Cancer May Be Reduced, ACS Says

November 22, 2002

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002